dipyridamole has been researched along with Liver Dysfunction in 5 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Case 2: Three-yr-old boy with IgA deficiency and liver disease." | 1.38 | Budd-Chiari syndrome in children and outcome after liver transplant. ( Cipriano, A; Furtado, E; Gomes, AC; Gonçalves, I; Pinto, C; Rubino, G, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomes, AC | 1 |
| Rubino, G | 1 |
| Pinto, C | 1 |
| Cipriano, A | 1 |
| Furtado, E | 1 |
| Gonçalves, I | 1 |
| Zoghbi, GJ | 1 |
| Patel, AD | 1 |
| Ershadi, RE | 1 |
| Heo, J | 1 |
| Bynon, JS | 1 |
| Iskandrian, AE | 1 |
| Oshima, T | 1 |
| Markiewicz, A | 1 |
| Semenowicz, K | 1 |
| Korczyńska, J | 1 |
| Hiraishi, M | 1 |
| Yamazaki, Z | 1 |
| Ichikawa, K | 1 |
| Kanai, F | 1 |
| Idezuki, Y | 1 |
| Onishi, K | 1 |
| Takahama, T | 1 |
| Inoue, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Coronary CT Angiography With Conventional Coronary Angiography in Liver and Lung Transplant Candidates.[NCT00727051] | 0 participants (Actual) | Observational | 2007-06-30 | Withdrawn (stopped due to No funding) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 other studies available for dipyridamole and Liver Dysfunction
| Article | Year |
|---|---|
Budd-Chiari syndrome in children and outcome after liver transplant.
Topics: Anticoagulants; Aspirin; Budd-Chiari Syndrome; Child, Preschool; Dipyridamole; Factor V; Female; Gas | 2012 |
Usefulness of preoperative stress perfusion imaging in predicting prognosis after liver transplantation.
Topics: Adenosine; Adult; Aged; Coronary Artery Disease; Dipyridamole; Exercise Test; Female; Humans; Liver | 2003 |
[Predictive factors for development of hemolytic uremic syndrome (HUS) and early intensive treatments for prevention of HUS enterohemorrhagic Escherichia coli infection].
Topics: Abdominal Pain; Adolescent; Age Factors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroi | 1997 |
[Dipyridamole pharmacokinetics in liver diseases].
Topics: Adult; Aged; Biological Availability; Dipyridamole; Female; Humans; Kinetics; Liver; Liver Diseases; | 1979 |
Plasma collection using nafamostat mesilate and dipyridamole as an anticoagulant.
Topics: Adult; Aged; Animals; Anticoagulants; Artificial Organs; Benzamidines; Dipyridamole; Dogs; Female; G | 1988 |